
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
Polyphenolics’ (Madera, CA) has patented its MegaNatural-BP grape seed extract, clinically shown to offer benefits to blood pressure and metabolic syndrome.
Polyphenolics’ (Madera, CA) has patented its MegaNatural-BP grape seed extract, clinically shown to offer benefits to blood pressure and metabolic syndrome. The patent covers the ingredient’s unique molecular composition that the company says is easily absorbed by the body and that facilitates migration to endothelial cells for improved vasodilatation.






